MNPR compared with BCRX: revenue, margins and what each company keeps, and the suppliers and customers both name

MNPRMonopar Therapeutics

Mkt capRevenueRevenue

BCRXBiocryst Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

MNPRMonopar Therapeutics

BCRXBiocryst Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MNPR

Reportimpliedrealized× implied

Aug 12 '26—▲+0.38%—

May 14 '26—▼−0.73%—

Mar 27 '26—▼−0.84%—

Nov 13 '25—▲+5.36%—

BCRX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Nov 4 '26±13.1%▼−3.85%×0.30

Aug 5 '26±10.0%▲+0.55%×0.06

= impliedMNPR realized, solidBCRX realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

May 6 '26

±8.9%

▼−2.21%

×0.25

Feb 26 '26±7.0%▲+4.64%×0.66

MNPRMonopar Therapeutics

71.11▲+5.79%· post 71.11

Mkt cap$479.4MRevenue—Revenue—

BCRXBiocryst Pharmaceuticals Inc

7.67▲+0.58%· post 7.67

ClosedNov 6 '26

Mkt cap$2.0BRevenue$180MQ3 FY26Revenue$875MFY25

Compare

ClosedNov 6 '26

MNPRMonopar Therapeutics

BCRXBiocryst Pharmaceuticals Inc

71.11▲+5.79%post 71.11

Price

7.67▲+0.58%post 7.67

$479.4M

Mkt cap

$2.0B

—

Revenue

$180MQ3 FY26

—

Revenue

$875MFY25

MNPR71.11▲+5.79%vsBCRX7.67▲+0.58%ClosedNov 6 '26